Volume 6, Issue 3, September 2020, Page: 280-284
Combination of Lactobacillus Rhamnosus LGG, Vitamin D3 and Zn in Preventing Atopic Dermatitis in Infancy
Ivana Filipovic, Hospital for Gynecology and Obstetric - Neonatology Department, University Hospital dr Dragisa Misovic, Begrade, Serbia
Olivera Ostojic, University Hospital dr Dragisa Misovic-Pediatric Department, Belgrade, Serbia
Vesna Vekovic, University Hospital dr Dragisa Misovic-Pediatric Department, Belgrade, Serbia
Milan Lackovic, Hospital for Gynecology and Obstetric - Neonatology Department, University Hospital dr Dragisa Misovic, Begrade, Serbia
Zorica Zivkovic, University Hospital dr Dragisa Misovic-Pediatric Department, Belgrade, Serbia; Faculty of Pharmacy, University Business Academy, Novi Sad, Serbia
Received: May 7, 2020;       Accepted: Jul. 8, 2020;       Published: Jul. 17, 2020
DOI: 10.11648/j.ajp.20200603.26      View  34      Downloads  56
Abstract
Introduction: With the prevalence of between 10-20% atopic dermatitis (AD) is one of the most common chronic diseases in infants and children. AD is characterized by itching and recurrent lesion. Mixtures of probiotics, including at the first place Lactobacillus rhamnosus LGG strain strains significantly decreased the risk of AD if given pre- and postnatally. Objective: The aim of the current study was to assess the effect of oral supplementation with LGG in infancy on eczema development and sensitization during the first 2 years of life. Material and methods: The study was a real life controlled observational study that included 96 patients (52 infants were treated with Lactobacillus rhamnosus with vitamin D3 and zinc, while the rest were advised to use only symptomatic treatment). Results: At the baseline the infants in the experiment group had higher values for SCORAD. During the follow up period a significant reduction in SCORAD was observed only in the group of participants who was treated with probiotics. They used also less topical treatments and antihistamines. Conclusions: This study has found that Lactobacillus rhamnosus GG (LGG) formulation with Zn and vitamin D3 supplementation during the postnatal period (in infancy and early childhood) reduce the severity of atopic dermatitis. Based on the findings it is recommended to introduce probiotic supplementation as well as vitamin D3 and zinc in infants and children with atopic dermatitis and positive family history.
Keywords
Atopic Dermatitis, Infants, Probiotics
To cite this article
Ivana Filipovic, Olivera Ostojic, Vesna Vekovic, Milan Lackovic, Zorica Zivkovic, Combination of Lactobacillus Rhamnosus LGG, Vitamin D3 and Zn in Preventing Atopic Dermatitis in Infancy, American Journal of Pediatrics. Vol. 6, No. 3, 2020, pp. 280-284. doi: 10.11648/j.ajp.20200603.26
Copyright
Copyright © 2020 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Mallol J, Crane J, von Mutius E, Odhiambo J, Keil U, Stewart A, et al. The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three: A global synthesis. Allergol Immunopathol (Madr) 2013; 41: 73-85.
[2]
Silverberg JI, Simpson EL. Association between severe eczema in children and multiple comorbid conditions and increased health- care utilization. Pediatr Allergy Im- munol 2013; 24: 476-86.
[3]
Kong HH, Oh J, Deming C, Con- lan S, Grice EA, Beatson MA, et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res 2012; 22: 850-859.
[4]
Akdis CA, Akdis M, Bieber T, Bindslev-Jensen C, Boguniewicz M, Eigenmann P, et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clin-ical Immunology/American Acad- emy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. Allergy 2006; 61: 969-987.
[5]
Galli E, Neri I, Ricci G, Baldo E, Barone M, Belloni Fortina A, Bernardini R, Berti I, Caffarelli C, Calamelli E, Capra L, Carello R, Cipriani F, Comberiati P, Diociaiuti A, El Hachem M, Fontana E, Gruber M, Haddock E, Maiello N, Meglio P, Patrizi A, Peroni D, Scarponi D, Wielander I, Eichenfield LF. Consensus conference on clinical management of pediatric atopic dermatitis. Ital J Pediatr 2016; 42: 46.
[6]
Raimer SS. Managing pediatric atopic dermatitis. Clin Pediatr 2000; 39: 1–14.
[7]
Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol 2016; 54: 1–15.
[8]
Carr WW. Topical calcineurin inhibitors for atopic dermatiis: review and treatment recommendations. Paediatr Drugs 2013; 15: 303–310.
[9]
Radulovic M, Filipovic Đ, Filipovic I, Update on food allergies. Prev Ped, 2019; God 5, Vol 1-2.
[10]
Filipovic I, Lackovic M, Ostojic O, Filipovic D Zivkovic Z. Probiotics for acute gastroenteritis - pediatrician attitude. Prev Ped, 2020; God 6 Vol 1-2. In press
[11]
Gomez de Agüero M, Ganal-Vonarburg SC, Fuhrer T et al (2016) The maternal microbiota drives early postnatal innate immune de- velopment. Science 2016; 351: 1296–1302.
[12]
Loubière LS, Lambert NC, Flinn LJ et al Maternal microchimerism in health. (2006).
[13]
Hill, C.; Guarner, F.; Reid, G.; Gibson, G. R.; Merenstein, D. J.; Pot, B.; Morelli, L.; Canani, R. B.; Flint, H. J.; Salminen, S.; et al. Expert consensus document. The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 2014; 11, 506–514.
[14]
Illi S, von Mutius E, Lau S, Nickel R, Grüber C, Niggemann B, et al. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol 2004; 113: 925-931.
[15]
Li L, Han Z, Niu X, Zhang G, jia Y, Zhang S, et al. Probiotic supplementation for prevention of atopc dermatitis in infants and children: a systematic review and meta-analysis. Am J Clin Dermatol 2018; [Epub ahead of print].
[16]
Penders J, Gerhold K, Stobberingh EE, Carel Thijs, Kurt Zimmer- mann, Lau S, et al. Establishment of the intestinal microbiota and its role in infantile eczema: results from a randomized placebo-con- trolled trial. J Allergy Clin Immunol 2013; 132: 601-607.
[17]
Szajewska, H.; Nowak-We ̨grzyn, A. Allergic and immunologic disorders. In The Microbiota in Gastrointestinal Pathophysiology Implications for Human Health, Prebiotics, Probiotics, and Dysbiosis; Floch, M. H., Ringel, Y., Walker, W. A., Eds.; Elsevier Inc.: New York, NY, USA, 2017; pp. 285–298.
[18]
Fiocchi, A.; Pawankar, R.; Cuello-Garcia, C.; Ahn, K.; Al-Hammadi, S.; Agarwal, A.; Beyer, K.; Burks, W.; Canonica, G. W.; Ebisawa, M.; et al. World allergy organization-mcmaster university guidelines for allergic disease prevention (GLAD-P): Probiotics. World Allergy Organ. J. 2015, 27, 4.
[19]
Ricci, G.; Cipriani, F.; Cuello-Garcia, C. A.; Broz ̇ek, J. L.; Fiocchi, A.; Pawankar, R.; Yepes-Nuñes, J. J.; Terraciano, L.; Gandhi, S.; Agarwal, A.; et al. A clinical reading on “World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Probiotics”. World Allergy Organ. J. 2016, 9, 9.
[20]
Kalliomäki, M.; Salminen, S.; Arvilommi, H.; Kero, P.; Koskinen, P.; Isolauri, E. Probiotics in primary prevention of atopic disease: A randomized placebo-controlled trial. Lancet 2001, 357, 1076–1079.
[21]
Cabana, M. D.; McKean, M.; Caughey, A. B.; Fong, L.; Lynch, S.; Wong, A.; Leong, R.; Boushey, H. A.; Hilton, J. F. Early probiotic supplementation for eczema and asthma prevention: A randomized controlled trial. Pediatrics 2017, 140, e20163000.
[22]
Kopp, M. V.; Hennemuth, I.; Heinzmann, A.; Urbanek, R. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: No clinical effects of Lactobacillus GG supplementation. Pediatrics 2008, 121, e850–e856.
[23]
Ou, C. Y.; Kuo, H. C.; Wang, L.; Hsu, T. Y.; Chuang, H.; Liu, C. A.; Chang, J. C.; Yu, H. R.; Yang, K. D. Prenatal and postnatal probiotics reduces maternal but not childhood allergic diseases: A randomized, double-blind, placebo-controlled trial. Clin. Exp. Allergy 2012, 42, 1386–1396.
[24]
Boyle, R. J.; Ismail, I. H.; Kivivuori, S.; Licciardi, P. V.; Robins-Browne, R. M.; Mah, L. J.; Axelrad, C.; Moore, S.; Donath, S.; Carlin, J. B.; et al. Lactobacillus GG treatment during pregnancy for the prevention of eczema: A randomized controlled trial. Allergy 2011, 66, 509–516.
[25]
Cuello-Garcia, C. A.; Broz ̇ek, J. L.; Fiocchi, A.; Pawankar, R.; Yepes Nuñez, J. J.; Terracciano, L.; Gandhi, S.; Agarwal, A.; Zhang, Y.; Schünemann, H. J. Probiotics for the prevention of allergy: A systematic review and meta-analysis of randomized controlled trials. J. Allergy Clin. Immunol. 2015; 136, 952–961.
[26]
Szajewska, H.; Horvath, A. A partially hydrolyzed 100% whey formula and the risk of eczema and any allergy: An updated meta-analysis. World Allergy Organ. J. 2017, 10, 27.
[27]
I. Annesi-Maesano, “Perinatal events, vitamin D, and the devel- opment of allergy,” Pediatric Research, vol. 52, no. 1, pp. 3–5, 2002.
[28]
N. A. Gray, A. Dhana, D. J. Stein N. P. Khumalo. Zinc and atopic dermatitis: a systematic review and metaanalysis. J Eur Acad Dermatol Venereol. 2019 Jun; 33 (6): 1042-1050. doi: 10.1111/jdv.15524. Epub 2019 Mar 15.
Browse journals by subject